Velarion Records
Free. Unsubscribe any time.

Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics, Inc. filed 20 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 35 transactions and 1,143,916 shares. 20 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Relay Therapeutics, Inc. 35

Adoption dates in Relay Therapeutics, Inc. 5

Results prints in Relay Therapeutics, Inc. 0

Trades before a print in Relay Therapeutics, Inc. 0

Interval to Relay Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Relay Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on February 22, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.